Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

6 results about "Acetamide" patented technology

Acetamide (systematic name: ethanamide) is an organic compound with the formula CH₃CONH₂. It is the simplest amide derived from acetic acid. It finds some use as a plasticizer and as an industrial solvent. The related compound N,N-dimethylacetamide (DMA) is more widely used, but it is not prepared from acetamide. Acetamide can be considered an intermediate between acetone, which has two methyl (CH₃) groups either side of the carbonyl (CO), and urea which has two amide (NH₂) groups in those locations.

Non-mammalian GnRH analogs and uses thereof in the immune system

InactiveUS20050043245A1Effective supervisionHigh affinityPeptide/protein ingredientsLuteinising hormone-releasing hormoneDiseaseD-Arginine
Specially designed non-mammalian GnRH, its analogs, or biometics resistant to degradation by peptidase, are disclosed. The GnRH analogs are further defined as analogs of GnRH II or salmon GnRH. These non-mammalian analogs incorporate D-arginine, D-leucine, D-tBu-Serine, D-Trp or other active D amino acids at position 6 and ethylamide, aza-Gly-amide or other Gly amide at position 10. The D-Arg (6)—GnRH II-ethylamide, D-Arg (6)—GnRH II-aza-Gly (10)-amide, the D-Arg (6)—salmon GnRH ethylamide, and D-Arg (6)—salmon GnRH-aza-Gly (10)-amide analogs are also provided, and demonstrate preferential binding to immune system non-mammalian GnRH receptors. These non-mammalian GnRH or its analogs, or long-acting preparation, biometics or their antibodies may be used in pharmaceutical preparation, and specifically in treatment of various immune system disorders. The non-mammalian GnRH or its analogs are also provided in pharmaceutical preparations that may be used clinically for treating immune system disorders when used in very low doses and administered in pulsatile fashion. The aza-Gly (10) amide non-mammalian analogs are yet other embodiments of the non-mammalian GnRH or its analogs provided as a part of the invention. The use of agents that regulate the production or antibodies or In addition, the detection of non-mammalian GnRH or GnRH II or the non-mammalian GnRH receptors may be used as a diagnostic tool.
Owner:SILER KHODR THERESA

Preparation method of N-diethylaminoacetyl-2,6-dimethylaniline quaternary ammonium salt

ActiveCN112390724AReverse time is shortThorough responseOrganic compound preparationCarboxylic acid amides preparationDimethylaniline N-oxideOrganic solvent
The invention belongs to the technical field of medicine synthesis, and particularly relates to a preparation method of N-diethylaminoacetyl-2,6-dimethylaniline quaternary ammonium salt. The method for preparing the N-diethylaminoacetyl-2,6-dimethylaniline quaternary ammonium salt comprises the following steps of: reacting 2-bromo-N-(2,6-dimethylphenyl)acetamide serving as a raw material with diethylaminoethanol to obtain an N-diethylaminoacetyl-2,6-dimethylaniline quaternary ammonium salt crude product, and further stirring and crystallizing the crude product in an organic solvent to obtain the N-diethylaminoacetyl-2,6-dimethylaniline quaternary ammonium salt pure product. The method provided by the invention has the advantages of simple reaction conditions and simplified preparation process, effectively enhances the yield and purity of the N-diethylaminoacetyl-2,6-dimethylaniline quaternary ammonium salt, and is suitable for industrial production.
Owner:LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products